In previous study, the carriers with Val75Met variant of PEMT gene demonstrated impaired PEMT activity, more frequent in NASH patients than healthy volunteers, lower BMI and more non-obese patients53, all supporting our observation. This evidence concerns the gene PEMT and metabolic dysfunction-associated steatohepatitis.